Taking Stock
Amicus' Crowley on Expanding Pipeline for Rare Diseases (Audio)
- Author: Vários
- Narrator: Vários
- Publisher: Podcast
- Duration: 0:08:45
- More information
Informações:
Synopsis
(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: HEALTHCARE: John Crowley, CEO of Amicus Therapeutics, on expanding its pipeline of treatments for rare and orphan diseases.
